References
- GBD 2015 Chronic Respiratory Disease CollaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet Respir Med20175969170628822787
- Asthma UKAnnual Asthma Survey: 2016 report Available from: https://www.asthma.org.uk/globalassets/get-involved/external-affairs-campaigns/publications/annual-asthma-care-survey/annualasthmasur-vey2016final.pdfAccessed June 19, 2017
- Global Initiative for AsthmaGINA report: global strategy for asthma management and prevention Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed March 8, 2018
- McCormackMCEnrightPLMaking the diagnosis of asthmaRespir Care200853558359018426612
- AaronSDVandemheenKLFitzgeraldJMReevaluation of diagnosis in adults with physician-diagnosed asthmaJAMA2017317326927928114551
- SierstedHCBoldsenJHansenHSMostgaardGHyldebrandtNPopulation based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild studyBMJ199831671326516579522784
- RabeKFVermeirePASorianoJBMaierWCClinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J200016580280711153575
- DemolyPAnnunziataKGubbaEAdamekLRepeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 yearsEur Respir Rev201221123667422379176
- BatemanEDBousheyHABousquetJCan guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL StudyAm J Respir Crit Care Med2004170883684415256389
- ZolnierekKBDimatteoMRPhysician communication and patient adherence to treatment: a meta-analysisMed Care200947882683419584762
- ResnickDJGoldRLLee-WongMFeldmanBRRamakrishnanRDavisWJPhysicians’ metered dose inhaler technique after a single teaching sessionAnn Allergy Asthma Immunol19967621451488595532
- BashetiIAThe effect of using simulation for training pharmacy students on correct device techniqueAm J Pharm Educ2014781017725657364
- Boehringer Ingelheim Pharmaceuticals IncHighlights of prescribing information Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021936s007lbl.pdfAccessed December 14, 2017
- Boehringer IngelheimAsthma: expanded indication for SPIRIVA® Respimat® for people 6 years and older Available from: https://www.boehringer-ingelheim.com/press-release/expanded-asthma-indication-spiriva-respimat-euAccessed March 20, 2018
- HamelmannEBatemanEDVogelbergCTiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trialJ Allergy Clin Immunol2016138244145026960245
- HamelmannEBernsteinJAVandewalkerMA randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaEur Respir J2017491160110027811070
- SzeflerSJMurphyKHarperTA phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthmaJ Allergy Clin Immunol201714051277128728189771
- VogelbergCEngelMLakiITiotropium add-on therapy improves lung function in children with symptomatic moderate asthmaJ Allergy Clin Immunol Pract Epub2018508
- VrijlandtEEl AzziGVandewalkerMSafety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trialLancet Respir Med20186212713729361462
- RodrigoGJAnticholinergics for asthma: a long historyCurr Opin Allergy Clin Immunol2018181384329040210
- NormansellRKewKMMathioudakisAGInterventions to improve inhaler technique for people with asthmaCochrane Database Syst Rev2017133CD012286
- BoniniMUsmaniOSThe importance of inhaler devices in the treatment of COPDCOPD Res Pract2015119
- LavoriniFFontanaGAUsmaniOSNew inhaler devices – the good, the bad and the uglyRespiration201488131524902629
- DekhuijzenPNLavoriniFUsmaniOSPatients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Patient Prefer Adherence2016101561157227574405
- AgustiABelEThomasMTreatable traits: toward precision medicine of chronic airway diseasesEur Respir J201647241041926828055
- WenzelSCastroMCorrenJDupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting b2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialLancet201638810039314427130691
- ChangABosséYTargeting single molecules in asthma benefits fewTrends Mol Med2016221193594527692867
- KerstjensHAMoroni-ZentgrafPTashkinDPTiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic statusRespir Med201611719820627492532
- PetersSPKunselmanSJIcitovicNTiotropium bromide step-up therapy for adults with uncontrolled asthmaN Engl J Med2010363181715172620979471